Agile Therapeutics
AGRX
#10952
Rank
โ‚ฌ9.33 M
Marketcap
1,35ย โ‚ฌ
Share price
0.00%
Change (1 day)
337.93%
Change (1 year)

EPS for Agile Therapeutics (AGRX)

EPS in 2024 (TTM): -3,58ย โ‚ฌ

According to Agile Therapeutics 's latest financial reports the company's current EPS (TTM) is -3,47ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -212,24ย โ‚ฌ an increase over its 2021 EPS that were of -1.397ย โ‚ฌ.

EPS history for Agile Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-3,58ย โ‚ฌ
2022-212,24ย โ‚ฌ-84.81%
2021-1.397ย โ‚ฌ30%
2020-1.075ย โ‚ฌ53.85%
2019-698,57ย โ‚ฌ-32.76%
2018-1.039ย โ‚ฌ
2016-1.809ย โ‚ฌ-26.28%
2015-2.454ย โ‚ฌ21.79%
2014-2.015ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,82ย โ‚ฌ-325.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
0,68ย โ‚ฌ-119.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
1,13ย โ‚ฌ-132.70%๐Ÿ‡บ๐Ÿ‡ธ USA
TherapeuticsMD
TXMD
0,07165ย โ‚ฌ-102.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
0,30ย โ‚ฌ-108.79%๐Ÿ‡บ๐Ÿ‡ธ USA